Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease

NCT01474421 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyskinesias
Drug-induced

Interventions

DRUG: AQW051
DRUG: AQW051
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals